CUV 0.00% $13.96 clinuvel pharmaceuticals limited

Ann: Change to Registered Office, page-3

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 846 Posts.
    lightbulb Created with Sketch. 1164
    I'm not telling you anything new, I will try just to mention facts in the following paragraph:

    Every single day ASIC data shows how highly manipulated CUV is. Short selling and the introduction of fake liquidity is done to control the price and absorb any buying pressure to maintain/manipulate the price (illegally IMO). The DOW and S&P are at very high levels yet CUV is near 5 year lows. The price of CUV is down about 25% in one year and about 10% for last 5 years. Company performing well with profits and growth and cash around $160 Million sitting idle - yet the financial fur of CUV is doing little to protect shareholders. The AGM did not make a single mention of short selling interest in this stock either long term or daily yet this is what has largely brought the price to where it is today. Timelines are rarely met and communication is weird and unlike any other company I have ever dealt with, for example is the recently mentioned goal of household name by Jan 2026 still being striven for?


    .

    Basically it has come to the point where I believe many shareholders don't care to differentiate any longer between company performance and share price performance. This is what short sellers want, and seemingly what the company is willing to accept, as any arguments they make about price performance are simply frail or totally miss the point. They just received a massive first strike at the AGM and are on track for a 2nd as short sellers will be hoping/striving for. The company by simply doing the same old stuff like comparing performance to MSB (which had a FDA rejection and would have tanked in any environment) and ignoring the short sellers will get the same old results. Ignoring shorting has not worked at any period for the last 5 years and the only way to respond to that and protect shareholder interests is by performing a substantial share buyback - which would still only use a tiny percentage of cash on hand and would give everlasting benefits to the company financials and EPS.

    The board just needs to ask the question if it is in shareholder interests that over the last several years that more than 2 Million fake liquidity short positions have been created in CUV and all of them with the intention to drive the share price lower? CUV was also driven from the ASX200 and was this in shareholder or the company interests?
    Shorters will try to never allow CUV back into the ASX200 while they are manipulating the price. The shorters have never gone away for a single day and I doubt they will unless they are driven away like PME and COH have done by running share buybacks. COH has a P/E about 65 and PME more than double that at over 130. CUV lagging at around low 20s.

    All IMO DYOR




    Last edited by Silverchair: 13/12/23
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.